top of page
Search

The Role of Hormones and Metabolic Regulators in Mental Health


Body

Mental health is influenced by a complex interplay of genetic, environmental, psychological, and biological factors. Among these, hormones and metabolic regulators play a crucial role in maintaining mental health. This article explores how these biological components contribute to mental health, with an emphasis on recent research findings.


Hormonal Influences on Mental Health


Hormones are chemical messengers that travel through the bloodstream to tissues and organs, influencing numerous bodily functions, including mood and behavior. Several hormones have been identified as significant contributors to mental health.


Cortisol: The Stress Hormone


Cortisol is produced by the adrenal glands and is released in response to stress. It plays a pivotal role in the body's stress response, but chronic elevation of cortisol levels can have detrimental effects on mental health. High cortisol levels have been linked to anxiety, depression, and other mood disorders. Research shows that prolonged stress and elevated cortisol can lead to hippocampal atrophy, which is associated with depression and cognitive decline (Sapolsky, 2000). Additionally, the dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, which controls cortisol production, is commonly observed in patients with major depressive disorder and anxiety disorders (Pariante & Lightman, 2008).


Chronic stress can lead to a persistent activation of the HPA axis, resulting in elevated cortisol levels. This condition, known as hypercortisolism, can impair the function of the hippocampus, a brain region essential for learning and memory. Furthermore, high cortisol levels can disrupt the balance of other neurotransmitters, such as serotonin and dopamine, which are crucial for mood regulation (Dedovic et al., 2009). These disruptions can contribute to the development of mood disorders.


Thyroid Hormones


Thyroid hormones, primarily thyroxine (T4) and triiodothyronine (T3), are essential for regulating metabolism. Hypothyroidism (low thyroid hormone levels) can lead to symptoms of depression, while hyperthyroidism (high thyroid hormone levels) can cause anxiety and irritability. The relationship between thyroid function and mental health highlights the importance of endocrine balance in psychological well-being (Fountoulakis et al., 2006). Studies have shown that even subclinical hypothyroidism, where hormone levels are only slightly abnormal, can be associated with mood disturbances and cognitive impairments (Hage & Azar, 2012).


The thyroid gland influences brain development and function throughout life. Thyroid hormones are involved in the regulation of neurogenesis, synaptogenesis, and myelination in the brain (Anderson, 2001). Alterations in thyroid hormone levels can therefore impact brain structure and function, contributing to mood disorders. For example, hypothyroidism can reduce serotonin levels in the brain, leading to depressive symptoms (Jackson, 1998).


Estrogen and Progesterone


Sex hormones, particularly estrogen and progesterone, significantly affect mood and mental health, especially in women. Fluctuations in these hormones during the menstrual cycle, pregnancy, and menopause can lead to mood swings, depression, and anxiety. Premenstrual dysphoric disorder (PMDD) and postpartum depression are examples of conditions where hormonal changes profoundly impact mental health (Yonkers et al., 2008). Estrogen is known to modulate neurotransmitter systems, including serotonin and dopamine, which are crucial for mood regulation (Sundstrom Poromaa & Gingnell, 2014).


Estrogen has neuroprotective effects, promoting neuronal growth and survival, and enhancing synaptic plasticity (Brinton, 2009). These effects are mediated through estrogen receptors in the brain, which influence the expression of genes involved in synaptic function and neuroprotection. The decline in estrogen levels during menopause is associated with an increased risk of depression and cognitive decline (Sherwin, 2003).


Progesterone, another sex hormone, also plays a role in mood regulation. It has anxiolytic (anxiety-reducing) properties through its metabolite allopregnanolone, which modulates the GABAergic system, the main inhibitory neurotransmitter system in the brain (Schiller et al., 2014). Imbalances in progesterone levels can therefore contribute to anxiety and mood disorders.


Testosterone


Testosterone, the primary male sex hormone, also influences mental health. Low levels of testosterone have been linked to depression and cognitive decline in men (Zarrouf et al., 2009). Testosterone therapy has been found to improve mood in men with hypogonadism, a condition characterized by low testosterone levels (Corona et al., 2013). Moreover, testosterone has been shown to impact aggression and risk-taking behavior, which can have psychological and social implications (Carré et al., 2017).


Testosterone modulates the activity of several neurotransmitter systems, including serotonin, dopamine, and gamma-aminobutyric acid (GABA), which are involved in mood regulation and cognitive function (Amanatkar et al., 2014). It also has neuroprotective effects, promoting neuronal growth and survival, and reducing inflammation in the brain (Caraci et al., 2011). These effects may help explain the association between low testosterone levels and depression.


Metabolic Regulators and Mental Health


Metabolic regulators include a variety of substances that influence energy balance, glucose metabolism, and overall metabolic health. These regulators are increasingly recognized for their role in mental health.


Insulin and Glucose Metabolism


Insulin, a hormone produced by the pancreas, regulates blood glucose levels. Dysregulation of insulin and glucose metabolism is a hallmark of diabetes, but it also has implications for mental health. Insulin resistance and hyperglycemia (high blood sugar) are associated with cognitive impairment and an increased risk of depression (Moulton et al., 2015). This connection suggests that maintaining metabolic health is vital for preserving mental health. The brain relies heavily on glucose for energy, and disruptions in glucose metabolism can affect neuronal function and mood (Biessels & Reagan, 2015).


Hyperglycemia can lead to the production of advanced glycation end products (AGEs), which promote inflammation and oxidative stress in the brain (Ceriello et al., 2012). These processes can damage neurons and impair synaptic function, contributing to cognitive decline and mood disorders. Insulin resistance, a condition where cells in the body become less responsive to insulin, can also affect brain function by impairing insulin signaling in the brain, which is important for synaptic plasticity and memory (Craft, 2005).


Leptin and Ghrelin


Leptin and ghrelin are hormones involved in regulating appetite and energy balance. Leptin, produced by adipose (fat) tissue, signals satiety, while ghrelin, produced in the stomach, stimulates hunger. Abnormal levels of these hormones have been linked to mood disorders. For example, low leptin levels are associated with depression, while high ghrelin levels are linked to anxiety and stress-related eating behaviors (Lu et al., 2006). Leptin receptors are found in the brain, including areas involved in emotion regulation, indicating a direct role in mood (Friedman, 2009).


Leptin has neuroprotective effects, promoting neuronal survival and reducing inflammation in the brain (Morris & Rui, 2009). It also modulates the activity of neurotransmitter systems involved in mood regulation, such as dopamine and serotonin (Diano et al., 1998). Ghrelin, on the other hand, has been shown to increase anxiety and depression-like behaviors in animal models, potentially through its effects on the HPA axis and neurotransmitter systems (Lutter et al., 2008).


Adiponectin


Adiponectin, another hormone produced by adipose tissue, plays a role in glucose regulation and fatty acid oxidation. Lower levels of adiponectin are associated with obesity and insulin resistance, conditions that are also linked to depression (Liu et al., 2016). Adiponectin has anti-inflammatory and neuroprotective properties, suggesting it may help protect against the inflammatory processes associated with depression (Spranger et al., 2003).


Adiponectin enhances insulin sensitivity and reduces inflammation in peripheral tissues, which can have beneficial effects on brain function (Yamauchi et al., 2001). It also crosses the blood-brain barrier and acts directly on the brain to promote neurogenesis and protect against neuronal injury (Thundyil et al., 2012). These effects highlight the potential of adiponectin as a target for therapeutic interventions in mood disorders.


Gut-Brain Axis and Metabolic Health


The gut-brain axis is a bidirectional communication network between the gastrointestinal tract and the brain. Gut microbiota, the community of microorganisms living in the digestive tract, play a crucial role in this interaction. Emerging research indicates that gut microbiota can influence brain function and behavior through metabolic pathways. Dysbiosis, an imbalance in gut microbiota, has been linked to anxiety, depression, and other mental health disorders (Cryan & Dinan, 2012). Short-chain fatty acids (SCFAs), metabolites produced by gut bacteria, can affect brain function and behavior, highlighting the importance of gut health in mental well-being (Silva et al., 2020).


The gut microbiota produce various metabolites, such as SCFAs, neurotransmitters, and neuroactive compounds, that can influence brain function through multiple mechanisms, including modulation of the immune system, the HPA axis, and the vagus nerve (Mayer et al., 2014). For example, SCFAs can cross the blood-brain barrier and have anti-inflammatory and neuroprotective effects in the brain (Stilling et al., 2016). Additionally, gut bacteria can produce neurotransmitters, such as serotonin and gamma-aminobutyric acid (GABA), which can influence mood and behavior (Cryan & Dinan, 2012). This intricate relationship between the gut microbiota and the brain underscores the potential for dietary and probiotic interventions in managing mental health disorders.


Conclusion


Understanding the role of hormones and metabolic regulators in mental health is essential for developing effective interventions and treatments. Hormones such as cortisol, thyroid hormones, estrogen, progesterone, and testosterone, as well as metabolic regulators like insulin, leptin, ghrelin, and adiponectin, significantly impact mental well-being. Additionally, the gut-brain axis highlights the intricate relationship between metabolic health and mental health. Future research should continue to explore these connections to enhance our understanding and treatment of mental health disorders. Effective management of these biological factors through lifestyle modifications, medication, and other therapeutic approaches could potentially improve mental health outcomes and quality of life for many individuals.


References


Amanatkar, H. R., Chibnall, J. T., Seo, B. W., Manepalli, J. N., & Grossberg, G. T. (2014). Impact of exogenous testosterone on mood: a systematic review and meta-analysis of randomized placebo-controlled trials. Annals of Clinical Psychiatry, 26(1), 19-32.


Anderson, G. W. (2001). Thyroid hormones and the brain. Frontiers in Neuroendocrinology, 22(1), 1-17.

- Biessels, G. J., & Reagan, L. P. (2015). Hippocampal insulin resistance and cognitive dysfunction. Nature Reviews Neuroscience, 16*(11), 660-671.


- Brinton, R. D. (2009). Estrogen-induced plasticity from cells to circuits: predictions for cognitive function. *Trends in Pharmacological Sciences, 30 (4), 212-222.

- Caraci, F., Giuffrida, M. L., Parenti, R., Copani, A., Nicoletti, F., & Drago, F. (2011). Neuroinflammation and cell death pathways in the CNS: role of sex hormones.


Current Neuropharmacology, 9*(4), 487-488.

- Carré, J. M., Geniole, S. N., Ortiz, T. L., Bird, B. M., Videto, A., & Bonin, P. L. (2017). Exogenous testosterone rapidly increases aggressive behavior in dominant and impulsive men. Biological Psychiatry, 82 (4), 249-256.


Ceriello, A., Esposito, K., Piconi, L., Ihnat, M., Thorpe, J., Testa, R., & Giugliano, D. (2012). Glucose "peak" and glucose "spike": impact on endothelial function and oxidative stress. Diabetes Research and Clinical Practice, 98 (3), 212-216.


Craft, S. (2005). Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiology of Aging, 26 (1), 65-69.


Cryan, J. F., & Dinan, T. G. (2012). Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience, 13 (10), 701-712.


Dedovic, K., D'Aguiar, C., & Pruessner, J. C. (2009). What stress does to your brain: a review of neuroimaging studies. *Canadian Journal of Psychiatry, 54*(1), 6-15.


Diano, S., Farr, S. A., Benoit, S. C., McNay, E. C., Da Silva, I., Horvath, B., ... & Horvath, T. L. (1998). Ghrelin controls hippocampal spine synapse density and memory performance. *Nature Neuroscience, 9 (3), 381-388.


Fountoulakis, K. N., Grammatikopoulos, I. A., Piliounis, C., & Papadopoulou, M. (2006). Thyroid function in clinical subtypes of major depression: an exploratory study. BMC Psychiatry, 6 (32).


Friedman, J. M. (2009). Leptin at 14 y of age: an ongoing story. The American Journal of Clinical Nutrition, 89 (3), 973S-979S.


Hage, M. P., & Azar, S. T. (2012). The link between thyroid function and depression. Journal of Thyroid Research, 2012, 590648.


Jackson, I. M. (1998). The thyroid axis and depression. Thyroid, 8(10), 951-956.


Liu, B., Fang, F., Liu, J., Wu, Y., Huang, W., & Zhu, M. (2016). Association of adiponectin with MDD: a meta-analysis. Journal of Affective Disorders, 206, 6-11.


Lu, X. Y., Kim, C. S., Frazer, A., & Zhang, W. (2006). Leptin: a potential novel antidepressant. Proceedings of the National Academy of Sciences, 103 (5), 1593-1598.


Lutter, M., Sakata, I., Osborne-Lawrence, S., Rovinsky, S. A., Anderson, J. G., Jung, S., ... & Zigman, J. M. (2008). The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nature Neuroscience, 11 (7), 752-753.


Mayer, E. A., Tillisch, K., & Gupta, A. (2014). Gut/brain axis and the microbiota. The Journal of Clinical Investigation, 124b(10), 4212-4219.


Morris, D. L., & Rui, L. (2009). Recent advances in understanding leptin signaling and leptin resistance. American Journal of Physiology-Endocrinology and Metabolism, 297 (6), E1247-E1259.


Moulton, C. D., Costafreda, S. G., Horton, P., Ismail, K., & Fu, C. H. (2015). Meta-analyses of structural regional cerebral effects in Type 1 and Type 2 diabetes. Brain Imaging and Behavior, 9(4), 651-662.


Pariante, C. M., & Lightman, S. L. (2008). The HPA axis in major depression: classical theories and new developments. Trends in Neurosciences, 31 (9), 464-468.


Sapolsky, R. M. (2000). Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. *Archives of General Psychiatry, 57 (10), 925-935.

- Schiller, C. E., Schmidt, P. J., & Rubinow, D. R. (2014). Allopregnanolone as a mediator of affective switching in reproductive mood disorders. *Psychopharmacology, 231 (17), 3557-3567.


Sherwin, B. B. (2003). Estrogen and cognitive functioning in women. Endocrine Reviews, 24 (2), 133-151.


Silva, Y. P., Bernardi, A., & Frozza, R. L. (2020). The role of short-chain fatty acids from gut microbiota in gut-brain communication. Frontiers in Endocrinology, 11, 25.


Spranger, J., Verma, S., Göhring, I., Bobbert, T., Seifert, J., Sindler, A. L., & Pfeiffer, A. F. (2003). Adiponectin does not directly regulate inflammatory or vasoactive mediators in human vascular wall cells. *Thrombosis and Haemostasis, 90 (6), 1137-1144.


Stilling, R. M., Dinan, T. G., & Cryan, J. F. (2016). Microbial genes, brain & behaviour–epigenetic regulation of the gut–brain axis. Genes, Brain and Behavior, 15 (1), 43-51.


Sundstrom Poromaa, I., & Gingnell, M. (2014). Menstrual cycle influence on cognitive function and emotion processing-from a reproductive perspective. Frontiers in Neuroscience, 8, 380.


Thundyil, J., Pavlovski, D., Sobey, C. G., Arumugam, T. V., & Tang, S. C. (2012). Adiponectin receptor signalling in the brain. British Journal of Pharmacology, 165 (2), 313-327.


Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., ... & Kadowaki, T. (2001). Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine, 8 (11), 1288-1295.


Yonkers, K. A., O’Brien, P. M. S., & Eriksson, E. (2008). Premenstrual syndrome. The Lancet, 371(9619), 1200-1210.


Zarrouf, F. A., Artz, S., Griffith, J., Sirbu, C., & Kommor,

Comments


bottom of page